ES2093043T3 - Procedimiento para la produccion de proteinas extrañas en estreptomicetos. - Google Patents

Procedimiento para la produccion de proteinas extrañas en estreptomicetos.

Info

Publication number
ES2093043T3
ES2093043T3 ES91106268T ES91106268T ES2093043T3 ES 2093043 T3 ES2093043 T3 ES 2093043T3 ES 91106268 T ES91106268 T ES 91106268T ES 91106268 T ES91106268 T ES 91106268T ES 2093043 T3 ES2093043 T3 ES 2093043T3
Authority
ES
Spain
Prior art keywords
streptomicets
procedure
production
proteins
strange
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106268T
Other languages
English (en)
Inventor
Klaus-Peter Dr Koller
Gunther Dr Riess
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2093043T3 publication Critical patent/ES2093043T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION TRATA DE UN PROCEDIMIENTO QUE SE UTILIZA PARA PRODUCIR PROTEINAS AJENA EN STREPTOMYCES Y CONSISTE EN EXPRESAR EN CELULAS ACTIVAS DE STREPTOMYCES Y CON ELEVADO RENDIMIENTO LOS GENES ESTRUCTURALES QUE CODIFICAN UNA PROTEINA DESEADA, LA SECUENCIA DE SEÑALES Y LOS PRIMEROS DIEZ AMINOACIDOS DE LA TENDENCIA DE AFINIDAD Y SECRETAR LA PROTEINA FUNDIDA EN EL MEDIO-
ES91106268T 1990-04-21 1991-04-18 Procedimiento para la produccion de proteinas extrañas en estreptomicetos. Expired - Lifetime ES2093043T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4012818A DE4012818A1 (de) 1990-04-21 1990-04-21 Verfahren zur herstellung von fremdproteinen in streptomyceten

Publications (1)

Publication Number Publication Date
ES2093043T3 true ES2093043T3 (es) 1996-12-16

Family

ID=6404857

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106268T Expired - Lifetime ES2093043T3 (es) 1990-04-21 1991-04-18 Procedimiento para la produccion de proteinas extrañas en estreptomicetos.

Country Status (29)

Country Link
EP (1) EP0453969B1 (es)
JP (1) JP3319605B2 (es)
KR (1) KR0168669B1 (es)
CN (1) CN1049248C (es)
AT (1) ATE142263T1 (es)
AU (1) AU630287B2 (es)
BR (1) BR9101587A (es)
CA (1) CA2040810C (es)
CZ (1) CZ285440B6 (es)
DE (2) DE4012818A1 (es)
DK (1) DK0453969T3 (es)
ES (1) ES2093043T3 (es)
FI (1) FI911882A (es)
GR (1) GR3021040T3 (es)
HR (1) HRP940770A2 (es)
HU (1) HU210358B (es)
IE (1) IE911322A1 (es)
IL (1) IL97903A0 (es)
LT (1) LT3686B (es)
LV (1) LV10494B (es)
NO (1) NO911557L (es)
NZ (1) NZ237882A (es)
PL (2) PL169596B1 (es)
PT (1) PT97427B (es)
RU (1) RU2055892C1 (es)
SK (1) SK110191A3 (es)
TW (1) TW213487B (es)
YU (1) YU48435B (es)
ZA (1) ZA912937B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100188800B1 (ko) * 1990-09-05 1999-06-01 이센브룩, 라피세 프리프로인슐린을 인슐린으로 전환시키기 위한 효소적 방법
DK0600372T3 (da) 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
EP0622376B1 (de) * 1993-04-27 2001-08-08 Hoechst Aktiengesellschaft Amorphe monosphärische Formen von Insulinderivaten
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
CN1061375C (zh) * 1996-07-19 2001-01-31 中国科学院上海生物工程研究中心 利用异源启动子在链霉菌中表达透明颤菌血红蛋白
ES2218622T3 (es) 1996-07-26 2004-11-16 Aventis Pharma Deutschland Gmbh Derivados de insulina con actividad de union al zinc incrementada.
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
CN1298742C (zh) * 2003-06-03 2007-02-07 上海新药研究开发中心 一种适合于高效表达的融合蛋白及其生产方法
RU2395296C1 (ru) * 2009-02-19 2010-07-27 Общество С Ограниченной Ответственностью "Концерн О3" Способ получения препарата проинсулина для перорального применения
CN104818291A (zh) * 2015-05-08 2015-08-05 江南大学 一种链霉菌重组表达载体的构建及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366246A (en) 1977-11-08 1982-12-28 Genentech, Inc. Method for microbial polypeptide expression
DE3418274A1 (de) 1984-05-17 1985-11-21 Hoechst Ag, 6230 Frankfurt Signalpeptid fuer die exkretion von peptiden in streptomyceten
DE3707150A1 (de) * 1987-03-06 1988-09-15 Hoechst Ag Tendamistat-derivate
DE3714866A1 (de) * 1987-05-05 1988-11-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
DE3715033A1 (de) 1987-05-06 1988-11-17 Hoechst Ag Verfahren zur isolierung von fusionsproteinen
DE3716722A1 (de) 1987-05-19 1988-12-01 Hoechst Ag Gentechnologisches verfahren zur herstellung von angiogeninen
DE3843713A1 (de) * 1988-04-25 1989-11-02 Henkel Kgaa Verwendung von calcinierten hydrotalciten als katalysatoren fuer die ethoxylierung bzw. propoxylierung
ES2081826T3 (es) * 1988-11-03 1996-03-16 Hoechst Ag Procedimiento para la preparacion de un producto previo de insulina en estreptomicetos.

Also Published As

Publication number Publication date
KR0168669B1 (ko) 1999-01-15
JP3319605B2 (ja) 2002-09-03
NZ237882A (en) 1993-12-23
LTIP1523A (en) 1995-06-26
TW213487B (es) 1993-09-21
FI911882A0 (fi) 1991-04-18
LT3686B (en) 1996-01-25
CZ285440B6 (cs) 1999-08-11
AU630287B2 (en) 1992-10-22
NO911557L (no) 1991-10-22
HU911302D0 (en) 1991-10-28
HU210358B (en) 1995-04-28
NO911557D0 (no) 1991-04-19
CN1055952A (zh) 1991-11-06
CZ110191A3 (en) 1993-08-11
GR3021040T3 (en) 1996-12-31
LV10494A (lv) 1995-02-20
DE4012818A1 (de) 1991-10-24
YU69691A (sh) 1995-12-04
DK0453969T3 (es) 1997-02-10
RU2055892C1 (ru) 1996-03-10
YU48435B (sh) 1998-07-10
CA2040810A1 (en) 1991-10-22
HRP940770A2 (en) 1997-06-30
EP0453969B1 (de) 1996-09-04
ZA912937B (en) 1991-12-24
SK110191A3 (en) 1995-07-11
IE911322A1 (en) 1991-10-23
FI911882A (fi) 1991-10-22
CA2040810C (en) 2001-07-24
PL169178B1 (pl) 1996-06-28
BR9101587A (pt) 1991-12-10
KR910018551A (ko) 1991-11-30
LV10494B (en) 1996-02-20
IL97903A0 (en) 1992-06-21
PL289953A1 (en) 1991-11-04
EP0453969A1 (de) 1991-10-30
JPH04228086A (ja) 1992-08-18
DE59108128D1 (de) 1996-10-10
ATE142263T1 (de) 1996-09-15
AU7515491A (en) 1991-10-24
PL169596B1 (pl) 1996-08-30
PT97427A (pt) 1992-01-31
PT97427B (pt) 1998-08-31
HUT57268A (en) 1991-11-28
CN1049248C (zh) 2000-02-09

Similar Documents

Publication Publication Date Title
ES2142363T3 (es) Materiales y metodos para la hipersecrecion de aminoacidos.
AU573523B2 (en) Functional human urokinase proteins
DK0815245T3 (da) Bioaktive IL 12 fusionsproteiner
ES2093043T3 (es) Procedimiento para la produccion de proteinas extrañas en estreptomicetos.
PT83898B (pt) Metodo para a producao de inibidores da trombina a base de proteinas com actividade de hirudina
ATE424410T1 (de) Interleukin-19.
AU8258591A (en) Human mk gene and protein sequence
ES2000859A6 (es) Un metodo para producir un vector de expresion bacteriana para la expresion de proteinas de fusion
AU2569588A (en) A method for the selective cleavage of fusion proteins
ES2000858A6 (es) Un metodo para producir un vector de expresion bacteriano para la expresion de proteinas de fusion
ECSP993285A (es) Sintesis recombinante de beta lipotropina y otros peptidos

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 453969

Country of ref document: ES